Aeolus Pharmaceuticals Inc. filed its 10-K on Dec 22, 2014 for the period ending Sep 30, 2014. In this report its auditor, Grant Thornton, gave an unqualified opinion expressing doubt that the company can continue as a going concern.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.000001 USD | -99.00% | -.--% | -.--% |
1st Jan change | Capi. | |
---|---|---|
-.--% | 152 | |
+23.37% | 47.02B | |
+49.84% | 41.86B | |
-0.94% | 41.76B | |
-4.32% | 28.8B | |
+11.29% | 26.05B | |
-20.92% | 19.15B | |
+3.20% | 12.55B | |
-2.67% | 11.82B | |
+30.23% | 12.34B |
- Stock Market
- Equities
- AOLS Stock
- News Aeolus Pharmaceuticals, Inc.
- Aeolus Pharmaceuticals Inc. Auditor Raises 'Going Concern' Doubt